Adenanthera pavonina trypsin inhibitor retard growth of Anagasta kuehniella (Lepidoptera: Pyralidae)
Article first published online: 16 MAR 2010
© 2010 Wiley Periodicals, Inc.
Archives of Insect Biochemistry and Physiology
Volume 73, Issue 4, pages 213–231, April 2010
How to Cite
Macedo, M. L. R., Durigan, R. A., da Silva, D. S., Marangoni, S., Freire, M. d. G. M. and Parra, J. R. P. (2010), Adenanthera pavonina trypsin inhibitor retard growth of Anagasta kuehniella (Lepidoptera: Pyralidae). Arch. Insect Biochem. Physiol., 73: 213–231. doi: 10.1002/arch.20352
- Issue published online: 19 MAR 2010
- Article first published online: 16 MAR 2010
- proteinase inhibitor;
- Adenanthera pavonina;
- plant-insect interaction
Anagasta kuehniella is a polyphagous pest that feeds on a wide variety of stored products. The possible roles suggested for seed proteinase inhibitors include the function as a part of the plant defensive system against pest via inhibition of their proteolytic enzymes. In this study, a trypsin inhibitor (ApTI) was purified from Adenanthera pavonina seed and was tested for insect growth regulatory effect. The chronic ingestion of ApTI did result in a significant reduction in larval survival and weight. Larval and pupal developmental time of larvae fed on ApTI diet at 1% was significantly longer; the larval period was extended by 5 days and pupal period was 10 days longer, therefore delaying by up to 20 days and resulting in a prolonged period of development from larva to adult. As a result, the ApTI diet emergence rate was only 28% while the emergence rate of control larvae was 80%. The percentage of surviving adults (%S) decreased to 62%. The fourth instar larvae reared on a diet containing 1% ApTI showed a decrease in tryptic activity of gut and that no novel proteolytic form resistant to ApTI was induced. In addition, the tryptic activity in ApTI -fed larvae was sensitive to ApTI. These results suggest that ApTI have a potential antimetabolic effect when ingested by A. kuehniella. © 2010 Wiley Periodicals, Inc.